HPS Pharmacies wish to advise that all suppliers are experiencing a supply interruption of teicoplanin, as follows:
Normal supplies of Targocid® are expected to resume by mid-March 2023; supplies of Teicoplanin Sandoz are expected in mid-April 2023.
Retain this notice in a prominent position, including in other related business until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates